COVID-19 vaccine development

Longitudinal profiles of executive functioning from infancy to 5 years of age-A FinnBrain Birth Cohort Study.

Karonen A. et al, (2026), Child Dev

Maternal views on RSV vaccination in the UK's second season.

O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Gagnon LL. et al, (2026), Leukemia

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines (Basel), 14

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.

Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37

Human-specific features of the cerebellum and ZP2-regulated synapse development.

Kim S-K. et al, (2026), Cell

Predicting how perturbations reshape cellular trajectories with PerturbGen

Chi Hao Ly K. et al, (2026)

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Advances in Alphavirus and Flavivirus Research II.

Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18

Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.

Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO Mol Med

Broad lessons from negative trials in rare diseases.

Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217

Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway.

Finkel RS. et al, (2026), Expert Rev Neurother, 26, 211 - 225

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review.

Fusani L. et al, (2026), Rev Med Virol, 36

Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge

Reiné J. et al, (2026), BMJ Immunology, 1, e000012 - e000012

Securing the future of immunisation: ESCMID’s vision

Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167

Search results

Showing results for